The primary objective was to explore whether postmortem serum PSA differs among PCa, BPH, and control cases, and the secondary objectives were to examine its relationships with age and PMI and the postmortem stability of PSA. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.